According to the INVS at the date of July 28 the hexagon was 1

It is a girl of 14 years, suffering from a serious disease complicated by a severe lung infection that is the first victim of the H1N1 flu virus in France. According to the Institute of Eve sanitaire (INVS) in charge of the epidemiological surveillance of the territory, the adolescent, hospitalized at the CHU in Brest, were actually infected with the H1N1 virus, but "clinical evaluation findings are not for death directly related to the virus A (H1N1).Despite the unknowns facing the clinical causes of death back in a week, the France becomes the fifth European country a register a death linked to swine flu pandemic. According to the INVS, at the date of July 28, the hexagon was 1.022 cases confirmed or probable influenza H1N1 which only four required hospitalization in an intensive care unit. "The death of this girl (...)". We also indicated the need to prepare for this vaccination, should protect the French. "It's a flu that can, for frail people as this girl have a very aggravating effect", found the Minister of health, Roselyne Bachelot, yesterday on TF1.

Yesterday, the Belgium also announced its first victim, a woman of 30 years who has succumbed to a "double pneumonia of viral origin." These deaths seem to confirm that the circulating strain preferentially infects young adults, and in particular agencies whose immune system is weakened. According to data published yesterday by the US CDC (Center for Disease Control), more than half 302 other deceased persons suffering from a chronic disease, immune deficiency, diabetes or asthma. In the Mexico, eight new people have died, bringing the number of victims to 146 in the country considered to be the home of origin of the pandemic.

In Europe, it is Britain that has recorded the largest number of victims (31), a total of more than 100,000 cases reported. On the old Continent, the pandemic mortality rate remains very low. It is of the order of 1 per 1,000 in France and 3 per 1,000 in Britain while the world average is encrypted to 4 pour1.000. The first outcome will inevitably relaunch the debate on health policy to put in place to contain a pandemic which should know a second probably more severe wave from the month of September. Many experts believe that in view of the strong contagion of active strain, between 20 and 40 of the French population would be reached by the end of the year. In France, Government and some companies have implemented plans to run in "degraded mode" based on a 40 absenteeism. Despite low virulence of H1N1, pandemic could result in tens of thousands of deaths in the hexagon. Very pessimistic in its forecasts, the World Health Organization considers same 6.8 billion of inhabitants of the planet have a risk of contracting the disease if the pandemic reinforces ".

Incompressible time

In this hypothesis, all developed countries have implemented a dual strategy to protect their nationals. On the one hand stockpile of precaution-based antiviral drugs and prophylactic equipment and, on the other hand, the command of vaccines to three major industrialists in the sector: Sanofi Pasteur, GSK and Novartis. This second solution, by far the most effective from the point of view of public health, faces a series of difficult compressible industrial times. The first batches of vaccines for clinical trials should be ready to mid-August or early September. In view of the urgency of the situation, the authorizations issued by the health agencies market will benefit from a "simplified procedure".